FLASH Stereotactic radiosurgery for brain metastases using proton Bragg peak tracking can achieve IMPT equivalent dosimetry.
Lynch N, Jackson J, Cheng C, Zhao X, Wei Z, Lin H, Morris B, Glide-Hurst C, Durkee B, Simone Ii CB, Kang M.Radiother Oncol. 2026 Mar 31:111512. doi: 10.1016/j.radonc.2026.111512. Online ahead of print.PMID: 41933594
Introducing ARONG, A 3D Reconstruction Method for Highly Deformed Histology.
Lee Y, Nickel KP, Kiernan MJ, Al Mukaddim R, Liu Y, Mitchell V, Ngawang T, Salamat S, Wilbrand SM, Graham M, Eliceiri KW, Kimple RJ, Dempsey RJ, Varghese T.J Imaging Inform Med. 2026 Mar 31. doi: 10.1007/s10278-026-01905-3. Online ahead of print.PMID: 41917246
Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular Profile.
Brower JV, Clements A, Chino J, Havrilesky L, Melamed A, Secord AA, Klopp AH.Pract Radiat Oncol. 2026 Mar 31:S1879-8500(26)00049-4. doi: 10.1016/j.prro.2026.01.012. Online ahead of print.PMID: 41914949 No abstract available.
Atovaquone-induced therapeutic rewiring of melanoma metabolism.
Ponce MB, Heaton AR, Burkard SK, D’Amato A, Boonpattrawong N, Skala MC, Patankar M, Barroilhet L.J Invest Dermatol. 2026 Mar 23:S0022-202X(26)00969-3. doi: 10.1016/j.jid.2026.03.009. Online ahead of print.PMID: 41881189 Free article. No abstract available.
Deducing cardiorespiratory motion of cardiac substructures using a novel 5D-MRI workflow for radiotherapy.
Ruff C, Naren T, Wieben O, Nagpal P, Johnson KM, Zhao J, Grist T, Baschnagel A, Glide-Hurst CK.Phys Med Biol. 2026 Mar 25. doi: 10.1088/1361-6560/ae5752. Online ahead of print.PMID: 41880763
A high-precision image-guided platform for studying spinal cord toxicity under ultra-high dose rate electron irradiation.
Zhou B, Guo L, Tsai YC, van der Kogel A, Wong JW, Iordachita I, Jiang K, Lu W, Medin P, Wang KK.Phys Med Biol. 2026 Mar 24. doi: 10.1088/1361-6560/ae56cb. Online ahead of print.PMID: 41875551
Multi-institutional MRI-based radiomic pilot study to measure the variations between scanner vendors and imaging sessions.
Duong S, Lee D, Glide-Hurst C, Paliwal B, Crosby J, Boss M, Cui Y, Huang M, Li H, Sheikh K, Kim T, Monroe J, Oh JH, Xiao Y, Sohn JW.Front Oncol. 2026 Mar 3;16:1686601. doi: 10.3389/fonc.2026.1686601. eCollection 2026.PMID: 41853315 Free PMC article.
Integrating biomarker-derived individual treatment response assessment into Bayesian trial design for personalized cancer treatment.
Kolias P, Ajdari A, Cicchetti A, Jeraj R, Toma-Dasu I, Thorwarth D, Gani C, Thieke C, Nicolay NH, Fiorino C, Bortfeld T, Niyazi M.Radiother Oncol. 2026 Mar 12;219:111484. doi: 10.1016/j.radonc.2026.111484. Online ahead of print.PMID: 41831619 Free article.
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.
Chen YW, Xiu J, Poorman KA, Ryan CJ, Gilg B, Oberley MJ, Sura G, Sledge GW Jr, Zhao SG, Tan A, Beltran H, McKay RR.JCO Precis Oncol. 2026 Mar;10:e2500756. doi: 10.1200/PO-25-00756. Epub 2026 Mar 5.PMID: 41785440
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language Models.
Callahan SC, Chrostek MR, Rydzewski N, Bootsma M, Helzer KT, Bakhtiar H, Morris ZS, Kosoff D, Lang JM, Ma VT, Sharifi M, Zhao SG.JCO Precis Oncol. 2026 Mar;10:e2500757. doi: 10.1200/PO-25-00757. Epub 2026 Mar 5.PMID: 41785439 Free PMC article.